Smiths Medical, a healthcare products company based in St. Paul, Minnesota, received approval from the United States Food and Drug Administration for its CADD-Solis VIP ambulatory infusion system. The system is designed to minimize medication errors.

According to a press release by the company, the CADD-Solis VIP variable infusion system includes medication safety software, a Smart infusion pump and specialized medication reservoirs that attach directly to the pump. Through the use of specialized real-time monitoring software, the system can alert operators if a mistake is being made with a patient’s medication. In addition, the system can stop the infusion process if it senses that a pump setting is outside of normal operating parameters. The system can recognize errors in prescriptions, dosing errors and issues with keypad programming.

The system includes five different delivery modes. This includes step, PCA (patient controlled analgesia), taper, intermittent and continuous. The system can be used for hydration, pain management, immunoglobulin infusions, chemotherapy, antibiotics and more.

Srini Seshadri is the president of Smiths Medical. In prepared remarks, he said, “We are extremely pleased to be able to continue that tradition with a smart, innovative new system that will help home care providers to prevent pump programming errors and improve patient safety. The new CADD®-Solis VIP system provides enhanced safety features and convenience for health care providers who want to provide optimal care for their infusion patients in the home.”

References

www.smiths.com/news.aspx